Home › Scleroderma › Michigan
Scleroderma clinical trials in Michigan
10 studies for Scleroderma are looking for participants at sites in Michigan.
Cities in Michigan
A Study to Assess the Efficacy and Safety of Efgartigimod PH20 SC in Adults With Systemic Sclerosis
- University of Michigan Hospital, Ann Arbor
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 24, 2026 · NCT06655155A Study to Test Whether Nerandomilast Helps People With Systemic Sclerosis
- University of Michigan, Ann Arbor
- Clinical Research Institute of Michigan, LLC - St. Clair Shores, Saint Clair Shores
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 17, 2026 · NCT07497087A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease
- GSK Investigational Site, Ann Arbor
RecruitingPhase 2/3
Ages 18 and older · All sexes · Updated Sep 8, 2026 · NCT05878717Platform Clinical Study for Conquering Scleroderma
- University of Michigan, Ann Arbor
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Aug 18, 2026 · NCT06195072RESET-SSc: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201, a CD19-CAR T Cell Therapy, in Subjects With Systemic Sclerosis
- University of Michigan, Ann Arbor
RecruitingPhase 2/3
Ages 18 to 75 · All sexes · Updated Aug 17, 2026 · NCT06328777A Phase 1/2 Study of NKX019 in Subjects With Immune-Mediated Diseases (Ntrust-2)
- Nkarta Investigational Site, Ann Arbor
RecruitingPhase 1/2
Ages 18 to 75 · All sexes · Updated Aug 7, 2026 · NCT06733935A Study of AZD0120 in Autoimmune Diseases
- Research Site, Ann Arbor
RecruitingPhase 1
Ages 18 to 75 · All sexes · Updated Jul 28, 2026 · NCT07295847Systemic Sclerosis DIet for GastrointESTinal Symptoms
- University of Michigan, Ann Arbor
Recruiting
Ages 18 and older · All sexes · Updated Jul 1, 2026 · NCT07402226A Study of Nemolizumab for the Treatment of Adults With Systemic Sclerosis
- Galderma Investigational Site # 8743, Ann Arbor
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Mar 31, 2026 · NCT07047690The Apollo Device in Systemic Sclerosis for the Management of fatiguE, Raynaud Phenomenon and qualiTy of Life
- University of Michigan, Ann Arbor
Recruiting
Ages 18 and older · All sexes · Updated Jan 8, 2026 · NCT06675344From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.